日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Corrigendum to "GBP1-CDK9-STAT3 signaling axis promotes osteosarcoma PD-L1 expression and immune escape" [Neoplasia 69 (2025) 101232]

对“GBP1-CDK9-STAT3 信号轴促进骨肉瘤 PD-L1 表达和免疫逃逸”的更正 [Neoplasia 69 (2025) 101232]

Jing, Doudou; Chen, Binghong; Liang, Ruqi; Li, Fei; Zhao, Bin; Pu, Feifei; Wu, Wei

GBP1-CDK9-STAT3 signaling axis promotes osteosarcoma PD-L1 expression and immune escape.

GBP1-CDK9-STAT3信号轴促进骨肉瘤PD-L1表达和免疫逃逸

Jing Doudou, Chen Binghong, Liang Ruqi, Li Fei, Zhao Bin, Pu Feifei, Wu Wei

Evans Blue Acts as a Selective Inhibitor of CaMKII-α to Impede the Progression of TCL Identified by HTS.

伊文思蓝作为 CaMKII-α 的选择性抑制剂,可阻止 HTS 鉴定的 TCL 的进展

Tian Jianru, Zhang Aiqin, Li Lansong, Liu Hong, Jiang Hui, Liang Ruqi

Inhibition of dual-specificity tyrosine phosphorylation-regulated kinase 2 perturbs 26S proteasome-addicted neoplastic progression

双特异性酪氨酸磷酸化调节激酶2的抑制会扰乱26S蛋白酶体依赖的肿瘤进展。

Banerjee, Sourav; Wei, Tiantian; Wang, Jue; Lee, Jenna J; Gutierrez, Haydee L; Chapman, Owen; Wiley, Sandra E; Mayfield, Joshua E; Tandon, Vasudha; Juarez, Edwin F; Chavez, Lukas; Liang, Ruqi; Sah, Robert L; Costello, Caitlin; Mesirov, Jill P; de la Vega, Laureano; Cooper, Kimberly L; Dixon, Jack E; Xiao, Junyu; Lei, Xiaoguang